bibliographic entry 10166887 [be/10166887]
https://w3id.org/oc/corpus/be/10166887

is a
content
  • Nauck M, Weinstock RS, Umpierrez GE, Guerci B, Skrivanek Z, Milicevic Z. Efficacy and safety of dulaglutide versus sitagliptin after 52 weeks in type 2 diabetes in a randomized controlled trial (AWARD‐5). Erratum in Diabetes Care 2015; 38: 538. Diabetes Care 2014; 37: 2149–2158. PMID: 24742660
references